Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting

Background. Transplantation of hepatitis C viremic (HCV+) deceased donor kidney transplants (DDKT) into aviremic (HCV–) recipients is a strategy to increase organ utilization. However, there are concerns around inferior recipient outcomes due to delayed initiation of direct-acting antiviral (DAA) th...

Full description

Bibliographic Details
Published in:Transplantation Direct
Main Authors: Beatrice P. Concepcion, MD, MS, Laura A. Binari, MD, Heidi Schaefer, MD, Scott Rega, MS, Irene Feurer, PhD, Saed Shawar, MBBS, Ruchi Naik, MD, Laura Hickman, MD, Jasmine Walker, MD, Meghan Kapp, MD, Kelly A. Birdwell, MD, MSCI, Anthony Langone, MD, J. Harold Helderman, MD, Bonnie Ann Sarrell, MD, Guneet Kochar, MD, Bernard Dubray, MD, Kristin Smith, MSN, RN, Heather O’Dell, MSN, ANP-BC, MMHC, April DeMers, MSN, ACNP-BC, Princess Shelton, APRN, FNP-BC, Roman Perri, MD, David Shaffer, MD, Rachel C. Forbes, MD, MBA
Format: Article
Language:English
Published: Wolters Kluwer 2021-10-01
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001217

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001217

Similar Items